Fresenius wins judgement on Akorn acquisition

2 October 2018 - Deborah Wilkes

Archived

A court in the US has ruled that Germany's Fresenius can terminate its planned USD4.75 billion acquisition of US generics, OTC and animal health company Akorn.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: